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Introduction: The aim of this prospective, randomized, double-blind study was to investigate 
the effect of articaine combined with ketamine on the success rate of inferior alveolar nerve 
block (IANB) in posterior mandible teeth with symptomatic irreversible pulpitis. Methods 
and Materials: Forty two adult patients with diagnosis of symptomatic irreversible pulpitis 
of a mandibular posterior tooth were selected. The patients received two cartridges of either 
containing 3.2 mL 4% articaine with epinephrine 1:200000 and 0.4 mL 50 mg/mL ketamine 
hydrochloride (A-ketamine group) or 3.2 mL 4% articaine with epinephrine 1:200000 and 
0.4 mL normal saline (A-saline group) using conventional IANB injections. Access cavity 
preparation started 15 min after injection. Lip numbness was required for all the patients. 
Success was considered as no or mild pain on the basis of Heft-Parker visual analog scale 
recordings upon access cavity preparation or initial instrumentation. Data were analyzed by 
independent student t, Mann-Whitney and Chi-square tests. Results: The success rates were 
55% and 42.9% for A-ketamine and A-saline group, respectively, with no significant 
differences between the two groups (P=0.437). Conclusion: Adding 0.4 mL 50 mg/mL 
ketamine hydrochloride to the articaine local anesthetic did not increase the efficacy of IANB 
for posterior mandibular teeth with symptomatic irreversible pulpitis. 
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Introduction 
nferior alveolar nerve block (IANB) is currently considered 
the most frequent local anesthesia technique for endodontic 
treatment of mandibular teeth [1, 2]. Clinical research has 
shown a high failure rate for this technique even with a correct 
application [3, 4]. On the other hand, achieving adequate 
anesthesia in teeth with symptomatic irreversible pulpitis has 
also been proven to be difficult [5-7]. Therefore, anesthetizing 
posterior mandibular teeth with irreversible pulpitis has been a 
serious challenge for the dentist, and research to solve the 
problem would be beneficial [7, 8]. 
Ketamine hydrochloride is a non-competitive antagonist of 
N-methyl-D-aspartate (NMDA) receptors which has analgesic 
effects in sub-anesthetic doses. The analgesic effect of ketamine 
is strong through both the central and peripheral nervous system 
paths [9]. It has been used alone and in combination with other 
local anesthetics such as lidocaine, in adeno-tonsillectomy and 
herniorrhaphy [9, 10]. Combination of a local anesthetic and 
subanesthetic dose of ketamine during surgical extraction of 
third molars provides good postoperative analgesia with less 
swelling and significantly less trismus [11].  
It should be noted that providing an effective, safe and painless 
anesthesia in teeth with symptomatic irreversible pulpitis is 
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critical [7, 12]. Kaviani et al. [13], showed that oral administration 
of ketamine might be beneficial for enhancing the anesthetic 
efficacy of IANB in mandibular teeth with symptomatic 
irreversible pulpitis. Based on ketamine analgesic effects, it may 
improve the success rate of anesthesia. However, anesthetic 
efficacy of adding ketamine to anesthetic solution in such teeth 
has not evaluated yet. Hence, the aim of this prospective, 
randomized, double-blind study was to investigate the effect of 
articaine plus ketamine on the success rate of IANB in posterior 
mandibular teeth with symptomatic irreversible pulpitis. 
Materials and Methods 
Forty two adult patients participated in this prospective, 
randomized, double-blind study. They were referred to an 
approved dental clinic of Isfahan University of Medical Sciences 
for endodontic treatment. The Regional Ethics Committee 
affiliated to Isfahan University of Medical Sciences approved the 
study protocol (Grant No.: 388485). Also this study has been 
registered in the Iranian Registry of Clinical Trial 
(IRCT138905024440N1). A full description of the study was given 
to the patients with irreversible pulpitis, and an informed consent 
was obtained from each of the patients. 
The participants of this study included the healthy (ASA I or 
ASA II) patients, aging between 18 to 50 years, who had a vital 
posterior mandibular tooth (premolar or molar) with pain and a 
prolonged response (in comparison with control group) to cold 
testing with Endo-Frost cold spray (Coltene Whaledent, 
Langenau, Germany) and diagnosed with irreversible pulpitis, 
had no severe periodontal disease, or any periapical pathological 
defect seen in the dental radiographs and no contraindications for 
the drugs and substances used in the study. The exclusion criteria 
were set in patients showing signs of pulp necrosis upon access 
cavity opening, patients showing any signs or symptoms of allergy 
to anesthetic solution, pregnancy and breast-feeding, patients 
with pain in more than one mandibular tooth, and those who 
refused to continue at any stage point. Therefore, each patient had 
a vital mandibular molar tooth with a clinical diagnosis of 
symptomatic irreversible pulpitis. 
The patients marked their initial pain on a Heft-Parker Visual 
Analogue Scale (HP-VAS) [14]. The scale is a 170-mm marked 
line which is divided into 4 sections with different terms 
describing the level of pain. No pain, mild pain, moderate pain, 
and severe pain were indicated by 0 mm, 1-54 mm, 55-113 mm, 
and 114-170 mm divisions, respectively. 
Articaine plus ketamine (A-ketamine) local anesthetic 
solution was prepared as follows: Under sterile conditions, 0.2 mL 
from a 1.8-mL cartridge of 4% articaine with 1:200000 
epinephrine (Artinibsa; Inibsa, Barcelona, Spain) was drawn and 
replaced with 0.2 mL ketamine (Ketamine Hydrochloride 50 
mg/mL, Rotexmedica, Trittau, Germany) using a glass micro liter 
syringe (Hamilton, Bonaduz, Switzerland). For articaine plus 
normal saline (A-saline) local anesthetic solution, 0.2 mL from a 
1.8 mL cartridge of 4% articaine with 1:200000 epinephrine was 
drawn and replaced with 0.2 mL of normal saline. A trained dental 
assistant prepared the two local anesthetic formulations and 
coded them in a random manner. Patients were assigned equally 
into two groups of A-ketamine or A-saline. One operator 
administered two cartridges of either A-ketamine or A-saline local 
anesthetic solution using IANB technique for each patient in a 
double-blind trial. Therefore, none of the participants and 
operators was aware of the group assignment. All the injections 
were performed using a 27-gauge, 1.5-inch needle (CK ject; CK 
Dental, Kor-Kyungji-do, Korea) attached to a standard aspirating 
dental injection syringe. Lip numbness was set as a criterion to 
IANB achievement. If lip numbness was not profound 15 min 
after the injection, the patient was excluded from the study. In the 
present study, no participant was excluded from the study as a 
result of a lack of lip numbness. Then, the teeth were isolated with 
a rubber dam, and access cavities were prepared. 
The patients were asked to rate the pain during the 
preparation of access cavity or initial file placement. If the patient 
felt pain, the treatment was stopped, and the patient marked their 
pain by using HP-VAS. The IANB injection was considered 
successful if patient felt no pain or mild pain (HP-VAS score≤54). 
Data were statistically analyzed using SPSS software (SPSS 
version 16.0, SPSS, Chicago, IL, USA) software. Comparisons 
between A-ketamine and A-saline groups for the success of the 
IANB, gender, and tooth type differences were analyzed by Chi 
square test; age was analyzed by independent t-test and initial pain 
was analyzed using the Mann-Whitney test. The comparison was 
considered significant at P<0.05. 
Results 
Out of 42 adult patients, 18 were women and 24 were men. The 
age range was 19-56 years, with mean±SD of 30±9.2 and 33±9.4 
years in the A-ketamine and A-saline groups, respectively. The 
age, gender, and initial pain ratings for the A-ketamine and A-
saline groups are presented in table 1. There were no differences 
in age, gender and initial pain between the two groups (P>0.05). 
Distribution of teeth for A-ketamine and A-saline groups is 
presented in table 2. There was no difference in tooth type 
between the two groups (P=0.68). The success rate of IANB was 
55.0% for A-ketamine and 42.9% for A-saline group. There was 
no statistically significant difference in success rates between the 
two groups (P=0.437). 
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Discussion 
This study was carried out to investigate the effect of articaine 
plus ketamine on the success rate of IANB in posterior mandible 
teeth with symptomatic irreversible pulpitis. The results showed 
that the success rate of IANB in A-ketamine group was a little 
more than A-saline group. However, the difference was not 
statistically significant. 
The participants’ age, sex, tooth types and initial pain records 
were not different between the two experimental groups; 
therefore, any possible effect from these factors was minimized. 
Lip numbness indicates successful IANB but does not guarantee 
pulpal analgesia or anesthesia in all patients [15-18]. Moreover, 
electric pulp test also seems to overestimate the rate of success 
when compared to the pain felt by the patients during treatment 
[17, 18] and cannot ensure pulpal analgesia either [19, 20]. This 
is attributed to the difference between pulpal anesthesia which is 
determined by the electric pulp test and pulpal analgesia which 
is determined through successful clinical pain control of the 
patient [18]. Therefore, the success of IANB was evaluated by 
measuring the pain level during endodontic access and initial 
instrumentation using HP-VAS, and further tests with an 
electric pulp tester were eliminated in this study. 
The success rates of anesthesia in the case of pulpitis have 
been reported to be as low as 20% [15, 21] to as high as 65-70% 
[18, 22]. The wide range of results could be partly due to 
differences in the length of time when anesthesia was tested, 
means of testing pulpal anesthesia or analgesia (e.g. thermal 
stimulus, electrical stimulus, or clinical treatment), and 
population differences [16]. 
Combining anesthetic solution with some medications has 
been evaluated to overcome the local anesthetic failure of 
mandibular molars with irreversible pulpitis [23]. Evidence 
showed that mixing anesthetic solution with mannitol improved 
the anesthetic efficacy of IANB [24]. However, mixing anesthetic 
solution with some other medications such as tramadol [25], 
hyaluronidase [26], meperidine [15], diphenhydramine [27], 
sodium bicarbonate [28], carbonate [29] did not increase the 
anesthetic efficacy of IANB in patients with irreversible pulpitis. 
The results of this study showed that mixing the articaine 
anesthetic solution with ketamine could not increase the success 
rate of IANB in patients with irreversible pulpitis. 
Ketamine interferes with sodium ion channels as a local 
anesthetic and shares with a binding site of commonly used local 
anesthetics, increasing their anesthetic effect [30]. 
Tverskoy et al. [31] showed that after herniorrhaphy, ulcers 
were infiltrated with a solution of 0.5% bupivacaine and 0.3% 
ketamine, and an increased level of anesthesia was 
demonstrated. Furthermore, they found that subcutaneous 
infiltration with 0.3% ketamine produced a local anesthetic 
effect. They claimed that ketamine acts via a peripheral 
mechanism and increases the anesthetic and analgesic actions of 
local anesthetics completely [31]. In addition, ketamine, as an 
NMDA receptor antagonist, can block the action potential of 
nerve fibers by affecting the sodium and potassium ion channels 
in their membranes. Moreover, its high lipid solubility and fast 
absorption in the surrounding tissue leads to slight sedative 
effects and also ketamine was administered as a local anesthetic 
in order to make use of its analgesic effects [32]. Accordingly, it 
was theorized that success of IANB is better in A-ketamine 
group than the A-saline group. Although the results of the 
present study showed that IANB success rate for the A-ketamine 
group was a little more than that for the A-saline group, 
although the difference was not statistically significant. 
The insignificant effect of adding ketamine to articaine 
might be partly because of their different onset of action. The 
effects of ketamine following an intramuscular injection starts in 
approximately 30 min and lasts for about 15-30 min [32].  
Table 1. Mean (SD) of preoperative values for the A-ketamine and A-saline groups 
Value A-ketamine A-saline P-value* 
Age (y) 30 (9.2) 33 (9.4) 0.473 
Gender 
Women 9 9 
0.451 
Men 11 13 
Initial Pain** 96 (30.2) 101 (30.0) 0.571 
* There were no significant differences between the two groups (P>0.05) 
Table 2. Distribution of teeth for A-ketamine and A-saline groups 
Tooth A-ketamine A-saline 
First premolar 3 (15%) 1 (5%) 
Second premolar 5 (24%) 5 (24%) 
First molar 7 (35%) 10 (48%) 
Second molar 6 (30%) 5 (24%) 
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Intravenous injection of ketamine may results in the complete 
emergence of its systemic side effects such as fidgetiness, dizziness, 
and pulmonary distress [32]. However, in the present study a few 
patients in the A-ketamine group appeared to have signs of 
dizziness. The major limitation of the present study was the sample 
size. Multicenter, prospective, randomized, double-blind trials with 
more sample size are suggested to achieve more comprehensive 
results.Conclusion 
Under the limited conditions of this study, adding 0.4 mL 50 
mg/mL ketamine hydrochloride to the articaine local anesthetic 
did not improve the success of the IANB for posterior 
mandibular teeth in patients with symptomatic irreversible 
pulpitis. 
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